STAT+

    China’s rapid ascent is reshaping drug development

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The NIH’s foreign subaward crackdown is scrambling global collaborations, while China’s rapid ascent is reshaping drug development. Meanwhile, Wave Life Sciences sheds half its value on underwhelming obesity results. Also, breaking: I’m adopting a rogue…

    Read More
    A two-story interior with many windows features a mural with the word “Pyrotech” and a logo of 10 circles arranged in a circle.

      How Chinese labs race for the next ‘first-in-class’ breakthrough

        Key Insights China’s researchers are racing to close the country’s gap with the US in chemistry-related advancements and secure the next frontier of innovations in materials, energy, and biomedicine. Increasing funding pools, investments in health-system reforms, and innovation-driven policies, such as integrating medical insurance data into R&D, are accelerating the rate of China’s gain in developing novel drugs, according…

      Read More
      STAT+

        China biopharma, JP Morgan 2026: Readout Newsletter

        Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It’s an exciting week not only for biotech M&A, but also for my city (Chicago) as we gear up for our big game this Saturday. Going into JPM, it’s good to be a…

        Read More
        Top 12 Most Asked Questions About AI

        Top 12 Most Asked Questions About AI

        Key Takeaways Agentic AI is the ability of machines to perform tasks requiring human intelligence, such as learning, decision-making, and problem-solving. Main branches of AI include Machine Learning, NLP, Computer Vision, Robotics, and Expert Systems, each unlocking different applications. Agentic AI is reshaping industries from healthcare and finance to contact centers by boosting efficiency and…

        Read More